共 50 条
- [21] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE - ASSESSMENT OF PATIENTS WITH OBESITY AND METABOLIC SYNDROME - GUIDELINE FROM THE BRAZILIAN SOCIETY OF BARIATRIC AND METABOLIC SURGERY ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2024, 37
- [24] Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study (vol 152, 155789, 2024) METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
- [26] Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes SCIENTIFIC REPORTS, 2025, 15 (01):